[Federal Register: March 7, 2003 (Volume 68, Number 45)]
[Notices]
[Page 11113]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07mr03-92]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30DAY-23-03]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210. Send written
comments to CDC, Desk Officer, Human Resources and Housing Branch, New
Executive Office Building, Room 10235, Washington, DC 20503. Written
comments should be received within 30 days of this notice.
Proposed Project: Evaluating the Impact of Lymphedema and a
Lymphedema Management Intervention for Women with Lymphatic Filariasis:
Understanding Issues Related to Quality of Life--New--National Center
for Infectious Diseases (NCID), Centers for Disease Control and
Prevention (CDC). Lymphatic filariasis, a mosquito-transmitted
parasitic disease affecting over 120 million people, is the second
leading cause of permanent disability worldwide. Globally, lymphatic
filariasis causes debilitating genital disease in an estimated 25
million men and lymphedema or elephantiasis of the leg in 15 million
people, mostly women in poverty stricken countries. The World Health
Organization (WHO) recently identified community management of chronic
lymphedema as one of the top twenty lymphatic filariasis research
priorities. Recent advances in the management of chronic lymphedema
include a prescribed hygiene and wound care intervention. This
intervention has shown promising results in preventing bacterial
infections thus reducing acute attacks, and anecdotally improving
overall quality of life, alleviating pain and preventing further
suffering.
This pilot study will provide a micro-level perspective of women's
own experiences of living with lymphedema and others responses to it,
illuminating the nature of the disease, the vulnerability of those
disabled by the disease, and the impact of an intervention to influence
the consequences of having the disease. This study will provide a
better understanding, through a combination of qualitative and
quantitative methods, the influence of lymphadema as well as the
efficacy of a lymphedema management intervention in reducing episodes
of bacterial infections and improving quality of life in women with
lymphedema in two developing countries.
Women will be queried through in-depth interviews, focus groups,
and questionnaire surveys as to the influence of lymphadema on their
lives. Quality of life domains that will be explored include physical
health, psychological health, social relationships, economic
productivity, spiritual health, stigma, and environment.
Recommendations will be derived from this study for the global
community of lymphatic filariasis researchers in developing countries
initiating national and local programs for the management of chronic
lymphedema. There are no costs to respondents.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden/
Forms respondents responses/ response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
In-depth Survey at Sites A and B................................ 50 1 60/60
Cross-sectional Survey at Sites A and B......................... 200 1 60/60
----------------------------------------------------------------------------------------------------------------
Dated: February 28, 2003.
Thomas Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation, Centers
for Disease Control and Prevention.
[FR Doc. 03-5394 Filed 3-6-03; 8:45 am]
BILLING CODE 4163-18-P